FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1484482114> ?p ?o ?g. }

• W1484482114 endingPage "735" @default.
• W1484482114 startingPage "730" @default.
• W1484482114 abstract "Please cite this paper as: Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytes. Experimental Dermatology 2010; 19: 730–735. Abstract: Epidermal growth factor receptor tyrosine kinase (EGFR-TK) is a transducer of mitogenic signals, and is involved in the pathogenesis and progression of a number of cancers, including non-small cell lung cancer (NSCLC). Gefitinib is an EGFR-TK inhibitor that is clinically used to treat NSCLC; however, this drug frequently causes adverse effects, including skin eruptions. The mechanism underlying these skin reactions is elusive, although it is assumed that they are caused by the inhibition of EGFR-TK signalling in epidermal and adnexal cells. In this article, we demonstrate by immunocytochemistry that the skin lesions of patients treated with oral gefitinib had higher expression of CCL2 and CCL5 compared to normal human epidermis. Further, PD153035, a gefitinib prototype, induced CCL2 and CCL5 mRNA and protein expression in HaCaT and HSC-1 keratinocyte cell lines with or without interleukin-1 (IL-1) treatment in vitro. PD153035 also reduced the levels of interleukin-1 receptor 2 (IL-1R2), an IL-1 decoy receptor. Moreover, we demonstrate that reduction in IL-1R2 by RNA interference increased IL-1-mediated CCL2 and CCL5 mRNA and protein expression. Taken together, our data strongly suggest that IL-1-mediated signalling is activated to induce the high expression of CCL2 and CCL5 via reduction in IL-1R2 in the skin lesions caused by gefitinib." @default.
• W1484482114 created "2016-06-24" @default.
• W1484482114 creator A5033780317 @default.
• W1484482114 creator A5037589641 @default.
• W1484482114 creator A5039206675 @default.
• W1484482114 creator A5067910323 @default.
• W1484482114 creator A5083759000 @default.
• W1484482114 date "2010-06-29" @default.
• W1484482114 modified "2023-10-03" @default.
• W1484482114 title "Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytes" @default.
• W1484482114 cites W1488576485 @default.
• W1484482114 cites W1534594872 @default.
• W1484482114 cites W1915518296 @default.
• W1484482114 cites W1967032939 @default.
• W1484482114 cites W1967413976 @default.
• W1484482114 cites W1976887761 @default.
• W1484482114 cites W1984204873 @default.
• W1484482114 cites W1987177419 @default.
• W1484482114 cites W1998085563 @default.
• W1484482114 cites W1998224687 @default.
• W1484482114 cites W2000392076 @default.
• W1484482114 cites W2005950142 @default.
• W1484482114 cites W2008444492 @default.
• W1484482114 cites W2010174111 @default.
• W1484482114 cites W2012741480 @default.
• W1484482114 cites W2016712837 @default.
• W1484482114 cites W2030168202 @default.
• W1484482114 cites W2038549079 @default.
• W1484482114 cites W2051120695 @default.
• W1484482114 cites W2056263610 @default.
• W1484482114 cites W2058196888 @default.
• W1484482114 cites W2074213282 @default.
• W1484482114 cites W2077098724 @default.
• W1484482114 cites W2090359261 @default.
• W1484482114 cites W2117867456 @default.
• W1484482114 cites W2126314379 @default.
• W1484482114 cites W2143464311 @default.
• W1484482114 cites W2146404049 @default.
• W1484482114 cites W2156142377 @default.
• W1484482114 cites W2165239282 @default.
• W1484482114 cites W2168539583 @default.
• W1484482114 cites W4210987759 @default.
• W1484482114 cites W4240064739 @default.
• W1484482114 doi "https://doi.org/10.1111/j.1600-0625.2010.01108.x" @default.
• W1484482114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20590818" @default.
• W1484482114 hasPublicationYear "2010" @default.
• W1484482114 type Work @default.
• W1484482114 sameAs 1484482114 @default.
• W1484482114 citedByCount "22" @default.
• W1484482114 countsByYear W14844821142012 @default.
• W1484482114 countsByYear W14844821142013 @default.
• W1484482114 countsByYear W14844821142014 @default.
• W1484482114 countsByYear W14844821142015 @default.
• W1484482114 countsByYear W14844821142016 @default.
• W1484482114 countsByYear W14844821142018 @default.
• W1484482114 countsByYear W14844821142019 @default.
• W1484482114 countsByYear W14844821142020 @default.
• W1484482114 countsByYear W14844821142021 @default.
• W1484482114 countsByYear W14844821142022 @default.
• W1484482114 countsByYear W14844821142023 @default.
• W1484482114 crossrefType "journal-article" @default.
• W1484482114 hasAuthorship W1484482114A5033780317 @default.
• W1484482114 hasAuthorship W1484482114A5037589641 @default.
• W1484482114 hasAuthorship W1484482114A5039206675 @default.
• W1484482114 hasAuthorship W1484482114A5067910323 @default.
• W1484482114 hasAuthorship W1484482114A5083759000 @default.
• W1484482114 hasConcept C116484652 @default.
• W1484482114 hasConcept C118995209 @default.
• W1484482114 hasConcept C121608353 @default.
• W1484482114 hasConcept C170493617 @default.
• W1484482114 hasConcept C180361614 @default.
• W1484482114 hasConcept C203014093 @default.
• W1484482114 hasConcept C2775960820 @default.
• W1484482114 hasConcept C2776090121 @default.
• W1484482114 hasConcept C2778820342 @default.
• W1484482114 hasConcept C2779438470 @default.
• W1484482114 hasConcept C2780580887 @default.
• W1484482114 hasConcept C42362537 @default.
• W1484482114 hasConcept C502942594 @default.
• W1484482114 hasConcept C54355233 @default.
• W1484482114 hasConcept C55493867 @default.
• W1484482114 hasConcept C62478195 @default.
• W1484482114 hasConcept C79186569 @default.
• W1484482114 hasConcept C79484868 @default.
• W1484482114 hasConcept C81885089 @default.
• W1484482114 hasConcept C86803240 @default.
• W1484482114 hasConcept C8891405 @default.
• W1484482114 hasConcept C95444343 @default.
• W1484482114 hasConceptScore W1484482114C116484652 @default.
• W1484482114 hasConceptScore W1484482114C118995209 @default.
• W1484482114 hasConceptScore W1484482114C121608353 @default.
• W1484482114 hasConceptScore W1484482114C170493617 @default.
• W1484482114 hasConceptScore W1484482114C180361614 @default.
• W1484482114 hasConceptScore W1484482114C203014093 @default.
• W1484482114 hasConceptScore W1484482114C2775960820 @default.
• W1484482114 hasConceptScore W1484482114C2776090121 @default.
• W1484482114 hasConceptScore W1484482114C2778820342 @default.
• W1484482114 hasConceptScore W1484482114C2779438470 @default.

• next